Following proof-of-concept in the lab setting and ex-vivo testing, a formal 50-case clinical trial completed in Hospital General Santa María del Puerto, Spain.

All participants underwent diagnostic or therapeutic intrauterine procedures. In all cases, the cervices were successfully dilated with the Aqueduct-100 cervical dilator, to the desired diameter in the targeted length of time and without adverse events that were directly connected to the dilation process. These trials validated the Company’s product as the optimal solution for patients undergoing cervical dilation prior to intrauterine procedures.

 

 

 

To view research: press here

 

product-alone

 

Leave a Reply

You must be logged in to post a comment.